Guo Xin, a marketing professor at Beijing Technology and Business University, said that as the Healthy China 2030 strategy ...

Florida accuses Planned Parenthood of racketeering over chemical abortion marketing, seeking massive damages in unprecedented ...

After U.S. President Donald Trump warned in September that acetaminophen – the active ingredient in Tylenol – is a potential ...

Texas AG Paxton is taking legal action to stop Kenvue from issuing dividends, potentially affecting Tylenol lawsuit funds.

The lawsuit was initially filed in Panola County. Attorneys representing Johnson and Johnson and Kenvue filed a notice this ...

We recently published 10 Stocks Jim Cramer Discussed Including His Palantir Deep Dive. Kimberly-Clark Corporation (NASDAQ:KMB ...

Andrew Slimmon, Senior Portfolio Manager at Morgan Stanley Investment Management, discussed broader market trends on CNBC, ...

Texas Attorney General Ken Paxton is asking a judge to block the maker of Tylenol from distributing $400 million of dividends ...

Texas files 2nd lawsuit against Tylenol makers seeking to block $400M dividend over alleged deceptive marketing and liability concerns.

Ken Paxton, Texas Attorney General, has sued Kenvue, the current manufacturer of Tylenol, and its former parent company ...

Kimberly-Clark said the cash-and-stock deal, including debt, has a value of more than $40 billion. The combination would ...

In today’s Pharmaceutical Executive Daily, we cover Eli Lilly and Novo Nordisk’s plans to bring their leading weight-loss medications to the TrumpRx platform, the State of Texas’ legal move to block ...